Molecular and metabolic features of colistin-resistant ST11 carbapenem-resistant Klebsiella pneumoniae
Journal of Medical Microbiology · 03.11.2026 · 75 (11)
DOI: 10.1099/jmm.0.002217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 03.11.2026. Verfasst von Ling Hao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guan…. Hauptthemen laut MEDLINE: Colistin, Klebsiella pneumoniae, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Guangzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Introduction
The emergence of colistin-resistant carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a critical threat to public health, a challenge that was exacerbated by the coronavirus disease 2019 (COVID-19) pandemic. Gap statement. The specific metabolic adaptations that underlie colistin resistance in high-risk sequence type 11 (ST11) CRKP clinical strains, particularly in direct comparison with their susceptible counterparts, remain poorly characterized.
Aim
To explore metabolic features associated with colistin resistance in clinical CRKP isolates. Methodology. Twelve CRKP strains, encompassing both colistin-resistant and colistin-susceptible isolates, were analysed for antimicrobial resistance profiles, virulence-associated genes, sequence types and biofilm formation capacity. Comparative untargeted metabolomics was performed to map metabolic shifts between the resistant and susceptible groups.
Results
All isolates belonged to the high-risk clone ST11, harboured the KPC-2 carbapenemase and carried multiple virulence genes, with K2 being the dominant serotype. All isolates formed biofilms, with resistant isolates showing enhanced capacity. Colistin resistance was chromosomally mediated by pmrB and mgrB mutations, with no plasmid-encoded mcr genes detected. Untargeted metabolomics identified 126 significantly differentially expressed metabolites (DEMs) between resistant and susceptible isolates. These DEMs were significantly enriched in lipids and lipid-like molecules. Colistin-resistant strains exhibited increased glycerophospholipids, sphingolipids and fatty acids, coupled with decreased metabolites from central carbon and amino acid pathways.
Conclusion
In this exploratory study, colistin resistance in these ST11 CRKP strains was associated with chromosomal alterations in pmrB and mgrB and with marked shifts in membrane-associated lipid metabolites. While these metabolic changes suggested membrane remodelling, they remain associative and require functional validation. Beyond resistance, the co-carriage of these traits with robust virulence gene expression highlights a critical clinical challenge, supporting the need for further research into combination therapies targeting these adaptive lipid pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.
- Institute of Clinical Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.
- Department of Laboratory Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.
- Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Förderung
- Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Science and Technology Plan Project
Zitieren
APA
Hao, L., Yang, X., & Ullah, N. (2026). Molecular and metabolic features of colistin-resistant ST11 carbapenem-resistant Klebsiella pneumoniae. Journal of Medical Microbiology, 75(11). https://doi.org/10.1099/jmm.0.002217
Vancouver
Hao L, Yang X, Ullah N. Molecular and metabolic features of colistin-resistant ST11 carbapenem-resistant Klebsiella pneumoniae. Journal of Medical Microbiology. 2026;75(11). doi:10.1099/jmm.0.002217
BibTeX
@article{Hao2026,
author = {Hao, Ling and Yang, Xiao and Ullah, Nadeem},
title = {Molecular and metabolic features of colistin-resistant ST11 carbapenem-resistant Klebsiella pneumoniae},
journal = {Journal of Medical Microbiology},
year = {2026},
volume = {75},
number = {11},
doi = {10.1099/jmm.0.002217}
}
EUVIMED